Trial Profile

Investigation of Pharmacokinetics, Safety, and Tolerability of Multiple Subcutaneous Doses of NNC0519-0130 in Japanese and Non-Japanese Male Participants

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 01 Jun 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs NNC 0519 0130 (Primary)
Indications Type 2 diabetes mellitus
Focus Pharmacokinetics
Sponsors Novo Nordisk

Most Recent Events

31 Oct 2023 Status changed from recruiting to completed.
27 Sep 2023 Drug NNC0519-0130 by oral route has removed from study protocol.
27 Sep 2023 Planned number of patients changed from 70 to 22.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com